Literature DB >> 17008713

Characterization of the five novel Ly-6 superfamily members encoded in the MHC, and detection of cells expressing their potential ligands.

Meera Mallya1, R Duncan Campbell, Begoña Aguado.   

Abstract

Lymphocyte Antigen 6 (Ly-6) superfamily members are cysteine-rich, generally GPI-anchored cell surface proteins, which have definite or putative immune related roles. There are 27 members of this family described so far in the human genome and 37 in the mouse. Five of them are clustered in the class III region of the human and mouse MHCs. Following computational analyses, we functionally characterized the encoded proteins by creating epitope-tagged fusion constructs to determine molecular weight, complex formation, subcellular localization, post-translational modifications and ligand binding. We found that all human and mouse proteins were glycosylated, and most could form part of larger complexes. Human and mouse Ly6G6c and Ly6G6d, and mouse Ly6g6e were found to be GPI-anchored cell surface proteins, highly expressed at the leading edges of cells, on filopodia, which are normally involved in cell adhesion and migration. However, analysis of Ly6G5c and Ly6G5b indicated that they are potentially secreted proteins. Our results indicate that there are two subclusters of related Ly-6 proteins in this region of the MHC, with Ly6G6c, Ly6G6d, and Ly6G6e forming one and Ly6G5c and Ly6G5b forming another. In addition, by FACS analysis we have found that the potential ligands for human LY6G6C, LY6G6D, and LY6G5C are expressed on K562 cells, an undifferentiated megakaryocyte cell line, indicating a potential role in hematopoietic cell differentiation. This characterization of the five MHC class III region Ly-6 family members is of great relevance, as they represent 18% of the human Ly-6 protein family and 50% of the secreted ones.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008713      PMCID: PMC2242401          DOI: 10.1110/ps.062242606

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  40 in total

Review 1.  Snake venom alpha-neurotoxins and other 'three-finger' proteins.

Authors:  V Tsetlin
Journal:  Eur J Biochem       Date:  1999-09

2.  lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS.

Authors:  J M Miwa; I Ibanez-Tallon; G W Crabtree; R Sánchez; A Sali; L W Role; N Heintz
Journal:  Neuron       Date:  1999-05       Impact factor: 17.173

3.  Ly6d-L, a cell surface ligand for mouse Ly6d.

Authors:  J Apostolopoulos; I F McKenzie; M S Sandrin
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

4.  Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium.

Authors: 
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

5.  Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse.

Authors:  Tao Xie; Lee Rowen; Begoña Aguado; Mary Ellen Ahearn; Anup Madan; Shizhen Qin; R Duncan Campbell; Leroy Hood
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

6.  Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes.

Authors:  H W Schroeder; Z B Zhu; R E March; R D Campbell; S M Berney; S A Nedospasov; R L Turetskaya; T P Atkinson; R C Go; M D Cooper; J E Volanakis
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

7.  The characterisation of novel secreted Ly-6 proteins from rat urine by the combined use of two-dimensional gel electrophoresis, microbore high performance liquid chromatography and expressed sequence tag data.

Authors:  Christopher Southan; Paul Cutler; Helen Birrell; John Connell; Kenneth G M Fantom; Matthew Sims; Narjis Shaikh; Klaus Schneider
Journal:  Proteomics       Date:  2002-02       Impact factor: 3.984

8.  Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to alpha-bungarotoxin and other neurotoxins.

Authors:  T J Fleming; C O'hUigin; T R Malek
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

9.  Ly-6I, a new member of the murine Ly-6 superfamily with a distinct pattern of expression.

Authors:  D L Pflugh; S E Maher; A L Bothwell
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

Review 10.  Tissue expression, structure and function of the murine Ly-6 family of molecules.

Authors:  T P Gumley; I F McKenzie; M S Sandrin
Journal:  Immunol Cell Biol       Date:  1995-08       Impact factor: 5.126

View more
  31 in total

1.  Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.

Authors:  Wanee Plengpanich; Stephen G Young; Weerapan Khovidhunkit; André Bensadoun; Hirankorn Karnman; Michael Ploug; Henrik Gårdsvoll; Calvin S Leung; Oludotun Adeyo; Mikael Larsson; Suwanna Muanpetch; Supannika Charoen; Loren G Fong; Sathit Niramitmahapanya; Anne P Beigneux
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

2.  Inferring the evolution of the major histocompatibility complex of wild pigs and peccaries using hybridisation DNA capture-based sequencing.

Authors:  Carol Lee; Marco Moroldo; Alvaro Perdomo-Sabogal; Núria Mach; Sylvain Marthey; Jérôme Lecardonnel; Per Wahlberg; Amanda Y Chong; Jordi Estellé; Simon Y W Ho; Claire Rogel-Gaillard; Jaime Gongora
Journal:  Immunogenetics       Date:  2017-12-18       Impact factor: 2.846

3.  GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.

Authors:  Anne P Beigneux; Loren G Fong; André Bensadoun; Brandon S J Davies; Monika Oberer; Henrik Gårdsvoll; Michael Ploug; Stephen G Young
Journal:  Circ Res       Date:  2014-11-11       Impact factor: 17.367

Review 4.  GPIHBP1, an endothelial cell transporter for lipoprotein lipase.

Authors:  Stephen G Young; Brandon S J Davies; Constance V Voss; Peter Gin; Michael M Weinstein; Peter Tontonoz; Karen Reue; André Bensadoun; Loren G Fong; Anne P Beigneux
Journal:  J Lipid Res       Date:  2011-08-15       Impact factor: 5.922

Review 5.  GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins.

Authors:  Anne P Beigneux; Brandon S J Davies; André Bensadoun; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2008-10-14       Impact factor: 5.922

6.  Modulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6.

Authors:  Martin Darvas; Marco Morsch; Ildiko Racz; Seifollah Ahmadi; Dieter Swandulla; Andreas Zimmer
Journal:  Eur Neuropsychopharmacol       Date:  2009-04-29       Impact factor: 4.600

7.  RNA-sequencing study of peripheral blood monocytes in chronic periodontitis.

Authors:  Yao-Zhong Liu; Pooja Maney; Jyoti Puri; Yu Zhou; Melody Baddoo; Michael Strong; Yu-Ping Wang; Erik Flemington; Hong-Wen Deng
Journal:  Gene       Date:  2016-01-23       Impact factor: 3.688

8.  Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase.

Authors:  Anne P Beigneux; Peter Gin; Brandon S J Davies; Michael M Weinstein; André Bensadoun; Loren G Fong; Stephen G Young
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

9.  Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.

Authors:  Anne P Beigneux; Remco Franssen; André Bensadoun; Peter Gin; Kristan Melford; Jorge Peter; Rosemary L Walzem; Michael M Weinstein; Brandon S J Davies; Jan A Kuivenhoven; John J P Kastelein; Loren G Fong; Geesje M Dallinga-Thie; Stephen G Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-19       Impact factor: 8.311

10.  Manipulating neuronal circuits with endogenous and recombinant cell-surface tethered modulators.

Authors:  Mandë Holford; Sebastian Auer; Martin Laqua; Ines Ibañez-Tallon
Journal:  Front Mol Neurosci       Date:  2009-10-30       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.